Form D Explorer
Aviceda Therapeutics, Inc. · CIK 1824762

Report a data issueCitable research briefCompare issuerPrivate research collection

Aviceda Therapeutics, Inc.

CIK 1824762 · Corporation · Inc. DELAWARE · CAMBRIDGE, Massachusetts · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
1
Original notices
0
Amendments
1
Activity
Jan 13, 2025
through Jan 13, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D/A · Jan 13, 2025

Reported offering amount
$207,499,882
Reported exemptions
Rule 506(b)
Reported amount sold
$74,999,940

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Same reported sales compensation recipient

Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.

Form D filings (1)